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SI Methods Construction of Low-Copy Vectors Expressing nanT and siaPQM.
To express the N-acetylneuraminic acid (Neu5Ac) transporter genes in trans, the nanT and siaPQM genes were amplified from genomic DNA of E. coli MG1655 and H. influenzae Rd KW2, respectively, using KOD Hot Start Polymerase (EMD Biosciences), and using oligos nanT-Asp718G and nanT-BamHI for nanT, and siaPQM-Asp719G and siaPQM-BamHI for siaPQM (see supporting information (SI) Table S1); these PCR products were cloned into the low copy-number vector pWKS30 (1) resulting in constructs pES1G (nanT) and pES7 (siaPQM).
Expression and Purification of SiaP and VC1779. SiaP was cloned into pBADnLIC to create a decahistidine tagged version (pBADnP). VC1779 was amplified by using primers pRY11F and pRY11R and cloned into pET20b. The resulting plasmid pRY11, expresses VC1779 with the leader sequence encoded by the pelB gene replacing its native signal sequence and contains a Cterminal hexahistidine tag.
For expression of ligand-free SiaP, MC1061/pBADnP was grown at 37°C in M9 minimal medium supplemented with 100 g/ml ampicillin, 0.2% (wt/vol) glycerol, 40 g/ml L-leucine, 40 g/ml L-isoleucine, 50 g/ml 4-methyl-5-␤-hydroxyethylthiazole (THZ), 2 g/ml thiamine, 50 g/ml nicotinic acid, and 1 mM MgSO 4 (2), to an A 650 of 1, at which point they were induced with 5 ϫ 10 Ϫ3 % L-arabinose. Cells were harvested after 2 h growth by centrifugation at 4430 ϫ g for 15 min at 4°C and were then resuspended in 50 mM potassium phosphate, pH 7.8, supplemented with 20% (wt/vol) glycerol. VC1779 was expressed in E. coli BL21(DE3) pLysS in M9 minimal medium with 100 g/ml ampicillin and 30 g/ml chloramphenicol. Cells were grown and protein prepared from periplasmic fractions as reported (3), except that only 0.5 mM IPTG was used for overnight induction at 25°C. For Western blot analysis, we used an anti-tetraHis antibody (Sigma).
SiaP was purified in a two-step procedure: The first step using Ni 2ϩ -NTA superflow resin and elution of the protein in WB containing 500 mM imidazole. After dialyzing the eluted protein against 20 mM Tris⅐HCl, pH 8.0, the second step involved DEAE Sepharose (Sigma) anion-exchange chromatography. The protein was eluted from the DEAE resin at 125 mM NaCl by using a 0-500 mM NaCl gradient. VC1779 was purified in a single step, by using a His-TRAP column (GE Healthcare) and eluting with 250 mM imidazole. Both proteins were dialyzed overnight at 4°C into 50 mM potassium phosphate pH 7.0 before storage at Ϫ80°C or use in the transport or ligand-binding assays.
Membrane Vesicle Preparation. The SiaQM-containing membrane vesicles were prepared by rupturing the cells in at least 2 passes through a French pressure cell (Thermo) at 10,000 psi. The cells were present in 50 mM potassium phosphate, pH 7.8, 20% (wt/vol) glycerol supplemented with 100 g/ml DNase I (Sigma) plus 1 mM MgCl 2 , and, after cell lysis, the mixture was incubated on ice for 5 min with 5 mM EDTA, pH 7. Unbroken cells and cell debris were removed by centrifugation at 10,000 ϫ g for 20 min. The resulting supernatant was then centrifuged at 200,000 ϫ g for 1 h at 4°C and the membrane pellets were resuspended in 50 mM potassium phosphate, pH 7.0, snapfrozen in liquid nitrogen, and stored at Ϫ80°C. L. lactis membrane vesicles were prepared as described in ref. 4 .
Purification of SiaQM. Membrane vesicles containing SiaQM were resuspended to 3.33 mg/ml protein and solubilized in 50 mM potassium phosphate, pH 7.8, 20% (wt/vol) glycerol, 200 mM NaCl, 0.5% (wt/vol) n-dodecyl-␤-D-maltoside (DDM), and 10 mM imidazole, pH 7.8, by inversion mixing and incubated on ice for 30 min. Insoluble material was removed by centrifugation at 200,000 ϫ g for 20 min at 4°C. The supernatant was incubated with Ni 2ϩ -NTA superflow resin (Qiagen, 0.1 ml/10 mg of protein; pre-equilibrated in 50 mM potassium phosphate, pH 7.8, 20% glycerol, and 200 mM NaCl (WB buffer) containing 0.04% DDM and 10 mM imidazole for 1 h in disposable polystyrene columns (Pierce). The resin was washed with 10 column volumes of WB supplemented with 0.04% DDM (wt/vol) and 40 mM imidazole, followed by 10 column volumes of WB with 0.1% n-decyl-␤,D-maltoside (DM) (wt/vol) and 40 mM imidazole. SiaQM was eluted with elution buffer [WB plus 0.1% DM (wt/vol) and 500 mM imidazole]. Five mM EDTA was added to the elution fractions. SiaP and VC1779 were purified by using nickel-affinity and anion-exchange chromatography (see SI Methods).
Membrane Reconstitution of SiaQM. Liposomes were prepared from a 3:1 (wt/wt) ratio of purified E. coli lipids and L-␣phosphatidylcholine from egg yolk (Avanti Polar Lipids). A volume of purified SiaQM containing 200 g of protein was diluted to 2 ml with 50 mM potassium phosphate, pH 7.8 containing 0.1% DM. This mixture was combined with 400 l of liposomes (at 20 mg of lipid/ml), resulting in a 1:40 ratio (wt/wt) of protein to lipids, which was then incubated on ice for 10 min. The mixture was rapidly diluted by mixing with 80 ml of 50 mM potassium phosphate, pH 7.0, on ice. Proteoliposomes were collected by centrifugation at 200,000 ϫ g for 2 h at 4°C. Proteoliposomes were frozen (liquid N 2 ) and then thawed slowly on ice, which was repeated five times [ 14 C]-Neu5Ac Uptake Assay in Whole Cells. For uptake into whole cells we used the BW25113 ⌬nanT strain from the KO collection (5), which we had modified to create an unmarked, in-frame ⌬nanT mutant (referred to simply as ⌬nanT) by using pCP20mediated removal of the Kan cassette followed by plasmid curing (6) . The ⌬nanT lesion in this strain was confirmed by PCR and sequencing. Aerobic cultures of ⌬nanT or ⌬nanT pES7 were grown overnight at 37°C in LB (supplemented with 100 g/ml ampicillin, where necessary), then diluted 1:100 into fresh 20-ml LB cultures. These were grown aerobically to midlog phase at 37°C, induced with 1 mM IPTG, and allowed to grow for a further 2 h. Cells were harvested by centrifugation at 4430 ϫ g for 8 min at 4°C and washed twice with 20 ml of 50 mM KPi, pH 7, and 2 mM MgSO 4 . The cells were finally resuspended in the same buffer in a small volume such that the OD 660 would equal 120. Cells were stored on ice until required.
For uptake assays, 7.6 l of cell suspension was added to 600 l of assay buffer to reach an OD 660 of 1.5. This was incubated at 30°C for 2 min under continuous airflow (water-saturated), at which point 8 M Neu5Ac (a 50:50 mixture of unlabeled Neu5Ac and [ 14 C]-Neu5Ac) was added. One hundred-l samples were taken at 0.5, 1, 2, 3, and 4 min and filtered onto cellulose nitrate membranes with a pore diameter of 0.45 m (BA85, Schleicher and Schuell). Filters were washed with 2 ml of 50 mM potassium phosphate buffer, pH 7. The cpm (cpma) for each sample was evaluated by using a liquid scintillation analyzer (Packard Tricarb 2900TR). The assay buffers used were 50 mM KPi, pH 7, 2 mM MgSO 4 , and 10 mM D-Li-lactate, which generates ⌬ H and ⌬ Li ; 50 mM KPi, pH 7, 2 mM MgSO 4 , and 20 mM NaCl, which generates a ⌬ Na and 50 mM KPi, pH 7, 2 mM MgSO 4 , and 20 mM LiCl, which generates a ⌬ Li .
In vivo Cold-Chase Experiments in Whole Cells.
For the in vivo cold-chase experiments in whole cells, we constructed a ⌬nanAT mutant of E. coli unable to take up and metabolize Neu5Ac (this strain will be fully described in Severi et al., manuscript in preparation) . Briefly, an unmarked, in-frame ⌬nanAT deletion (consisting of the first six codons of nanA fused to the last 12 codons of nanT, and flanked at each end by Ϸ500 bp of homologous sequence) was cloned into the temperaturesensitive episomal vector pKO3 (7) , and the resulting construct was used to recombine the lesion into the WT E. coli strain BW25113 (6) as described in ref. 7 . The presence of the correct ⌬nanAT mutation in this strain, which was named SEVY1, was confirmed by PCR and sequencing.
For [ 14 C]-Neu5Ac uptake assays, single colonies from freshly streaked LB plates of SEVY1 pES1G/pES7 were grown for 6-8 h in LB ampicillin, washed twice in M9 medium, and inoculated at a 1:100 dilution in M9 ampicillin supplemented with 2 mg/ml glucose and 1 mM IPTG. After overnight growth, the cultures were refreshed in the same medium at a starting OD 650 of 0.1, and grown at 37°C until the OD 650 reached 0.5, when they were harvested, washed three times with M9, resuspended to a final OD 650 of 3 in M9, and stored on ice until use. To assay sialic acid uptake, the cells were diluted 10 times in 4 ml of prewarmed M9, and allowed to acclimatize at 37°C for 2 min with stirring, after which time the assay was initiated by adding [ 14 C]-Neu5Ac (Sigma) at a final concentration of 1 M with continued stirring. The time-course of radiotracer accumulation was followed as described in ref. 8 except that smaller aliquots (200 l) were taken. The cold chase was performed by adding 1 mM cold Neu5Ac, or an identical volume of solvent (dH 2 O), immediately after taking the aliquot at t ϭ 1.5 min. The protein concentration within each sample was determined by a modified Lowry assay (9) . GCGGTACCGTAAAAGAAGGAGATATACATATGATGAAATTGACAAAAC SiaPQM SiaPQM-BamHI GCGGATCCTTATGGTATCAATAGATTTGG siaPQM *After comparison of the SiaQM sequence to other closely related proteins, it was clear that the original annotation of H. influenzae Rd KW-20 used an incorrect start codon. We thus used a later start codon that resulted in a SiaQM protein of 616 aa
